Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of dexamethasone intravitreal implant (Ozurdex) and
compare it with safety and efficacy of intravitreal bevacizumab in eyes with macular edema
after plaque radiotherapy of uveal melanoma.